From: The Barretos short instrument for assessment of quality of life (BSIqol): development and preliminary validation in a cohort of cancer patients undergoing antineoplastic treatment
BSIqol
ICC
95% CI
p-value
Global
0.946
0.907–0.969
<0.001
Physical
0.900
0.828–0.942
Emotional
0.851
0.744–0.913
Functional
0.932
0.883–0.960
Social
0.736
0.553–0.847